Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OPK | US
0.09
5.66%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
1.68
1.62
1.74
1.60
OPKO Health Inc. a healthcare company engages in the diagnostics and pharmaceuticals businesses in the United States Ireland Chile Spain Israel Mexico and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection diagnosis evaluation monitoring and treatment of diseases including esoteric testing molecular diagnostics anatomical pathology genetics women's health and correctional healthcare to physician offices clinics hospitals employers and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology infectious diseases vaccines and immunology; OPK88004 an orally administered selective androgen receptor modulator; OPK88003 a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP) a once-weekly human growth hormone injection; and Factor VIIa-CTP a novel long-acting coagulation factor being developed to treat hemophilia. In addition it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops manufactures markets and sells pharmaceutical nutraceutical veterinary and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets distributes and sells pharmaceutical products in a range of indications including cardiovascular products vaccines antibiotics gastro-intestinal products hormones and others. The company also operates pharmaceutical platforms in Ireland Chile Spain and Mexico. The company was founded in 1991 and is headquartered in Miami Florida.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
38.7%1 month
55.8%3 months
47.9%6 months
50.1%-
64.52
0.79
0.19
0.14
-3.79
1.87
-2.87
-165.46M
1.17B
1.17B
-
-33.85
19.10
-31.40
-16.59
25.48
24.45
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.20
Range1M
0.50
Range3M
0.55
Rel. volume
1.61
Price X volume
8.18M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 38.46 | 1.24B | -0.39% | 14.46 | 258.31% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 15.89 | 1.00B | 0.38% | n/a | 656.27% |
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.55 | 913.01M | 0.10% | 82.57 | 178.54% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 21 | 850.58M | -2.19% | 350.00 | 109.99% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 5.06 | 808.28M | -0.98% | 63.25 | -199.01% |
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 15.56 | 717.73M | 1.30% | 11.61 | 73.76% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 5.21 | 575.57M | 0.58% | n/a | 0.00% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 15.14 | 421.49M | 0.13% | n/a | 0.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.53 | 412.50M | 2.95% | n/a | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 2.88 | 381.82M | -0.69% | n/a | 42.12% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pitney Bowes Inc | PBI | Building Products & Equipment | 7.07 | 1.27B | 0.43% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.74 | 1.17B | -2.65% | n/a | 0.00% |
Interface Inc | TILE | Textile Manufacturing | 18.88 | 1.10B | 0.16% | 16.71 | 106.26% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 21.94 | 990.13M | 0.14% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 36.37 | 743.39M | 4.66% | n/a | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.25 | 722.36M | 0.32% | 56.82 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.91 | 621.28M | 1.18% | 14.94 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 49.80 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.79 | - | Cheaper |
Ent. to Revenue | 1.87 | - | Cheaper |
PE Ratio | - | 28.45 | - |
Price to Book | 0.79 | 11.25 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 47.88 | - | Lower Risk |
Debt to Equity | 0.19 | -0.58 | Expensive |
Debt to Assets | 0.14 | 0.43 | Cheaper |
Market Cap | 1.17B | - | Emerging |